The Daily Pennsylvanian2d
Here’s how Penn researchers are using mRNA technology to treat cancer, celiac disease
Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
mRNA transfer between cells reveals novel intercellular communication pathway
Cell-to-cell communication is essential throughout all forms and stages of life, and many communication mechanisms are well ...
Why Moderna (MRNA) Went Up on Tuesday?
We recently published a list of 10 Firms Kick Off Shortened Trading Week With Impressive Gains. In this article, we are going ...
Committee hears 2 hours of testimony on bill to ban mRNA vaccines for 10 years
Sen. Brandon Shippy brought the bill and presented it with a slate of out-of-state physicians, many of whom have been linked ...
Circular mRNA produces 200 times more protein, enhancing precision therapy potential
Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...
StockStory.org on MSN2d
Why Moderna (MRNA) Stock Is Up Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning session after it continued to build on the ...
mRNA research explores new frontiers in celiac disease treatment
Jax Bari, an 11-year-old from Philadelphia, shows me a photo of himself. It's hard to look at; in it, he's sprawled out on ...
mRNA vaccine against tuberculosis shows efficacy in mice, results pave way for larger trials
Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity and offers better long-term protection compared to the ...